NLG802
Product Specifications
UNSPSC Description
NLG802 is a proagent of indoximod, an orally active indoleamine 2,3-dioxygenase (IDO) inhibitor.
Target Antigen
Indoleamine 2,3-Dioxygenase (IDO)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/nlg802.html
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
CC(C)C[C@H](N)C(N[C@@H](C(OCC)=O)CC1=CN(C)C2=CC=CC=C12)=O.Cl
Molecular Weight
395.92
References & Citations
[1]Kumar S, et al. Discovery of indoximod prodrugs and characterization of clinical candidate NLG802. Eur J Med Chem. 2020 Jul 15;198:112373.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-145346/NLG802-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-145346/NLG802-SDS-MedChemExpress.pdf
Clinical Information
Phase 1
CAS Number
2071683-99-1
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
DOC2A (Double C2-like Domain-containing Protein alpha, Doc2, Doc2-alpha) (MaxLight 405)
DOC2A (Double C2-like Domain-containing Protein alpha, Doc2, Doc2-alpha) (MaxLight 405)
FOXJ1 (Forkhead Box Protein J1, Forkhead-related Protein FKHL13, Hepatocyte Nuclear Factor 3 Forkhead Homolog 4, HFH-4, FKHL13, HFH4) (Biotin)
FOXJ1 (Forkhead Box Protein J1, Forkhead-related Protein FKHL13, Hepatocyte Nuclear Factor 3 Forkhead Homolog 4, HFH-4, FKHL13, HFH4) (Biotin)